4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-26-009596
Options or other derivatives
- Director acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hyperscale Data, Inc. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant or award : show line 1 in the form Series D Convertible Preferred Stock | +7,500 | $1,000.00 | $7,500,000 | 7,500 | I |
Loading xslF345X06/marketforms-73681.xml…